Supresa: A saffron extract that claims to reduce appetite and cravings, but there is scarce concrete evidence linking it to GLP-1 enhancement, especially in diverse or diabetic populations
Our Data Protection Officer (DPO) can also be reached using the same contact information (please specify "Attention: DPO")
doi: 10.1016/j.chest.2021.08.010 308 GiloteauxLHansonMRKellerBA
Despite the widespread morbidity and mortality burden of HFpEF, current treatment options are limited, said corresponding author Nils Krger, MD, of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Womens Hospital, a founding member of the Mass General Brigham healthcare system
References Huang Y, Li Y, Pan H, Han L
Large-scale research data, including pooled data from three randomized double-blind placebo-controlled cardiovascular outcome trials, and a nationwide Danish registry-based cohort in over 120,000 patients, suggests GLP-1s reduce the incidence of dementia, especially in patients with type 2 diabetes [19]